WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 2'4601 Infant (under 12 months) mortality rate: 362
GDP / capita (US$): 7'6691 Child (under 5 years) mortality rate: 452

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 754  742  729  717  705  564  536  413 
Births 15  15  15  15  15  16  20  18 
Surviving infants 14  14  14  14  14  15  18  16 
Pop. less than 5 years 71  71  70  70  70  75  90  73 
Pop. less than 15 years 212  212  213  213  215  229  233  176 
Female 15-49 years 199  195  191  186  181  132  116  91 

Number of reported case

(Click for retrospective incidence data for Bhutan)
Diphtheria
Japanese encephalitis 27 
Measles 10  21  418  173  1'642 
Mumps 20  198  262  218  1'967 
Pertussis 18  464 
Polio*
Rubella 15 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 23 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Bhutan)
Vaccine year result method % card seen                                                
BCG 2007  100  EPI   98  97  95  95  95  96  97  87  43 
DTP1 2007  100  EPI   98  97  97  93  94  96  99 
DTP3 2007  100  EPI   98  97  97  95  95  96  92  84 
HepB_BD          64  60  29 
HepB3 2007  100  EPI   98  97  97  95  95  96  98 
Hib3          97  97 
JapEnc         
MCV 2007  99  EPI   98  94  95  95  95  98  79  21 
MCV2          89  90  95  85  90 
PCV1         
PCV3         
Pol3 2007  100  EPI   98  97  97  95  95  96  98  84 
Rota1         
Rota_last         
Rubella1          94  95  95  98 
TT2plus 2007  97  EPI   98  39  79  80  80  80  76  63 
PAB         
VAD1          97  44  90 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Bhutan)
BCG 97  95  95  96  94  97  99  43 
DTP1 97  97  98  94  97  96  98  25 
DTP3 97  97  95  91  93  92  96 
HepB3 97  97  95  91  93  98 
HepB_BD 64  60  29 
Hib3 97  97 
MCV 94  95  95  95  94  78  93  21 
MCV2 89  90  95  85  79 
PAB 83  89  89  89  89  85  63 
PCV3
Pol3 97  97  95  92  93  98  96 
Rota_last

Number of districts in the country 20  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 85
From 80 to 89% 15
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 24 months; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 12 years; +2, +6 momths; Yes 12 to 18 years girls
HepB Birth;
MR 9, 24 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Td 6, 12 years; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2018  2'013  2'013  2009-2013  2009-2013  2009-2013  2009-2013 
Nº of districts with microplans that include activities to raise immunization coverage number 20  20  20  20  20     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 20  20  20  20  20  20  20 
Nº districts with DTP3 coverage >=80% number 20  19  19  18  17  19 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  95  95  90  85  95  25 
Nº districts with measles (MCV1) coverage >=95% number 13  14  15   
% of districts with MCV1 coverage >=95% From 0 to 100% 45  40  40  65  70  75   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%   14   

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.